Cargando…

Bisphosphonates and risk of atrial fibrillation: a meta-analysis

INTRODUCTION: Bisphosphonates are the most commonly used drugs for the prevention and treatment of osteoporosis. Although a recent FDA review of the results of clinical trials reported no clear link between bisphosphonates and serious or non-serious atrial fibrillation (AF), some epidemiologic studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seo Young, Kim, Min Jung, Cadarette, Suzanne M, Solomon, Daniel H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875664/ https://www.ncbi.nlm.nih.gov/pubmed/20170505 http://dx.doi.org/10.1186/ar2938

Ejemplares similares

Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
por: Kim, Dae Hyun, et al.
Publicado: (2015)

Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011)

The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
por: Park, Ji-Hyun, et al.
Publicado: (2022)

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
por: Mak, Anselm, et al.
Publicado: (2009)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis
por: Grosso, Anthony, et al.
Publicado: (2009)

Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort
por: Kim, Seo Young, et al.
Publicado: (2011)

Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study
por: Herrera, L., et al.
Publicado: (2015)

Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study
por: Erichsen, R, et al.
Publicado: (2011)

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis
por: Yang, Hung-Yu, et al.
Publicado: (2018)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Exercise capacity and risk of incident atrial fibrillation in healthy adults
por: Kim, Ju Youn, et al.
Publicado: (2023)

Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
por: Caldeira, Daniel, et al.
Publicado: (2019)

Effects of Atrial Fibrillation on the Outcome of the Rehabilitation in Patients With Cerebral Infarction
por: Kim, Ja-Young, et al.
Publicado: (2014)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)

Glycemic variability and the risk of atrial fibrillation: a meta-analysis
por: Li, Wei, et al.
Publicado: (2023)

Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias
por: Kim, Yun Gi, et al.
Publicado: (2021)

Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis
por: Gong, Mengqi, et al.
Publicado: (2020)

Bisphosphonates and risk of cancers: a systematic review and meta-analysis
por: Li, Yuan-Yuan, et al.
Publicado: (2020)

Statin Effects in Atrial Fibrillation-Related Stroke: A Systematic Review and Meta-Analysis
por: Eun, Mi-Yeon, et al.
Publicado: (2020)

Long-term Prognosis of Paroxysmal Atrial Fibrillation and Predictors for Progression to Persistnt or Chronic Atrial Fibrillation in the Korean Population
por: Im, Sung II, et al.
Publicado: (2015)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Risk Factors between Patients with Lone and Non-Lone Atrial Fibrillation
por: Lee, Sung Ho, et al.
Publicado: (2013)

Patent Foramen Ovale May Decrease the Risk of Left Atrial Thrombosis in Stroke Patients With Atrial Fibrillation
por: Baik, Minyoul, et al.
Publicado: (2023)

Alcohol Consumption and the Risk of Incident Atrial Fibrillation: A Meta-Analysis
por: Giannopoulos, Georgios, et al.
Publicado: (2022)

Association of high estimated glomerular filtration rate with risk of atrial fibrillation: a nationwide cohort study
por: Kang, Min Kyoung, et al.
Publicado: (2023)

Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?
por: Kim, Sang-Min, et al.
Publicado: (2016)

Periodontal disease and risk of atrial fibrillation or atrial flutter: A systematic review and meta‐analysis
por: Leelaviwat, Natnicha, et al.
Publicado: (2023)

Electrocardiographic predictors of early recurrence of atrial fibrillation
por: Choi, Ji‐Hoon, et al.
Publicado: (2021)

Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors
por: Choi, Sun Young, et al.
Publicado: (2020)

Meta-analysis of effect of vernakalant on conversion of atrial fibrillation
por: Yan, He, et al.
Publicado: (2013)

Prophylactic Atrial Fibrillation Ablation in Atrial Flutter Patients without Atrial Fibrillation: A Meta-Analysis with Trial Sequential Analysis
por: Xie, Xinxing, et al.
Publicado: (2018)

Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis
por: Peng, Rui, et al.
Publicado: (2020)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022)

Functional Insufficiency of Mitral and Tricuspid Valves Associated With Atrial Fibrillation: Impact of Postoperative Atrial Fibrillation Recurrence on Surgical Outcomes
por: Kim, Kitae, et al.
Publicado: (2023)

Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022)

Risk indexation and atrial fibrillation
por: Nguyen, Thanh H., et al.
Publicado: (2019)

Atrial fibrillation in cancer survivors – a systematic review and meta-analysis
por: Bao, Yueyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dispjdeav3lb2k1k4337cjsm5j